A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis—a seasonal viral illness that hospitalizes thousands of babies each year. The Bronchiolitis Endotracheal Surfactant Study (BESS) trial is the largest-ever randomized study of surfactant for bronchiolitis.
This article was originally published on MedicalXpress.com

